Antisense c-myc fragments induce normal differentiation cycles in HL-60 cells

European Journal of Clinical Investigation

Volumn 36, Issue 1, 2006, Pages 49-57

  Chen, J P ^a   Chen, L ^a   Leek, J ^b,d   Lin, C ^c,e  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c PEKING UNION MEDICAL COLLEGE   (China)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e CANCER HOSPITAL   (China)

Author keywords

Ad ASc myc; Ad LacZ; c myc gene; Differentiation; HL 60 cells

Indexed keywords

BETA GALACTOSIDASE; MYC PROTEIN; PROTAMINE SULFATE; PROTEIN C FOS; RECOMBINANT PROTEIN;

ADENOVIRUS VECTOR; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HL 60; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFECTION; MORPHOLOGY; NUCLEIC ACID PROBE; ONCOGENE C MYC; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANTISENSE ELEMENTS (GENETICS); APOPTOSIS; CELL DIFFERENTIATION; CELL DIVISION; FLOW CYTOMETRY; GENE THERAPY; GENES, MYC; GENETIC VECTORS; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 33645053245     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2006.01589.x     Document Type: Article

References (35)

1. Hong WK Sporn MB Recent advances in chemoprevention of cancer Science 1997 278 1073 7
2. Suh N Luyengi L Fong HH Kinghorn AD Pezzuto JM Discovery of natural product chemopreventive agents utilizing HL-60 cell differentiation as a model Anticancer Res 1995 15 233 9
3. Dalla-Favera R Wong-Staal F Gallo RC Onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient Nature 1982 299 61 3
4. Ramsay RG Barton AL Gonda TJ Targeting c-Myb expression in human disease Expert Opin Ther Targets 2003 7 235 48
5. Dang CV Resar LM Emison E Kim S Li Q Prescott JE et al. Function of the c-Myc oncogenic transcription factor Exp Cell Res 1999 253 63 77
6. Cory S Vaux DL Strasser A Harris AW Adams JM Insights from Bcl-2 and Myc: Malignancy involves abrogation of apoptosis as well as sustained proliferation Cancer Res 1999 59 1685s 92s
7. Little CD Nau MM Carney DN Gazdar AF Minna JD Amplification and expression of the c-myc oncogene in human lung cancer cell lines Nature 1983 306 194 6
8. Munzel P Marx D Kochel H Schauer A Bock KW Genomic alterations of the c-myc protooncogene in relation to the overexpression of c-erbB2 and Ki-67 in human breast and cervix carcinomas J Cancer Res Clin Oncol 1991 117 603 7
9. Cole MD McMahon SB The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation Oncogene 1999 18 2916 24
10. Dang CV c-Myc target genes involved in cell growth, apoptosis, and metabolism Mol Cell Biol 1999 19 1 11
11. Smith DP Bath ML Harris AW Cory S T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC Oncogene 2005 24 3544 53
12. Lee LK Roth CM Antisense technology in molecular and cellular bioengineering Curr Opin Biotech 2003 14 505 11
13. Kurreck J Wyszko E Gillen C Erdmann VA Design of antisense oligonucleoides stabilized by locked nucleic acids Nucl Acids Res 2002 30 1911 8
14. Koppelhus U Nielsen PE Cellular delivery of peptide nucleic acid (PNA) Adv Drug Deliv Rev 2003 55 267 80
15. Dargelos E Moyen C Dedieu S Veschambre P Poussard S Vuillier-Devillers K et al. Development of an inducible system to assess p94 (CAPN3) function J Biotechnol 2002 96 271 9
16. Yu JY DeRuiter SL Turner DL RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells Proc Natl Acad Sci USA 2002 99 6047 52
17. Shen L Zhang C Ambrus JL Wang JH Silencing of human c-myc oncogene by poly-DNP-RNA Oligonucleotides 2005 15 23 5
18. Chen JP Lin C Xu CP Zhang XY Fu M Deng YP et al. Molecular therapy with recombinant antisense c-myc adenovirus for human gastric carcinoma cells in vitro and in vivo J Gastro Hepto 2001 16 22 8
19. Zhao X Wang X Zhou C Peng R Yan S Wu M Abrupt reduction of c-myc expression by antisense RNA inducing terminal differentiation and apoptosis of a human esophageal cancer cell Sci China B 1995 38 580 9
20. Birnie GD The HL60 cell line: a model system for studying human myeloid cell differentiation Br J Cancer Suppl 1988 9 41 5
21. Dalton WT Jr. Ahearn MJ McCredie KB Freireich EJ Stass SA Trujillo JM HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3 Blood 1988 71 1 242 7
22. Grimwade D Enver T Acute promyelocytic leukaemia: where does it stem from? Leukemia 2004 18 375 84
23. Chroboczek J Bieber F Jacrot B The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2 Virology 1992 186 280 5
24. Cantwell MJ Sharma S Friedmann T Kipps TJ Adenovirus vector infection of chronic lymphocytic leukaemia B cells Blood 1996 88 4676 83
25. Matsuura M Yamazaki Y Sugiyama M Kondo M Ori H Nango M et al. Polycation liposome mediated gene transfer in vivo Biochim Biophys Acta 2003 1612 136 43
26. Sakakura C Hagiwara A Tsujimoto H Ozaki K Sakakibara T Oyama T et al. The anti-proliferative effect of proliferating cell nuclear antigen-specific antisense oligonucleotides on human gastric cancer cell lines Surg Today 1995 25 184 6
27. Bestilny LJ Riabowol KT A role for serine proteases in mediating phorbol ester-induced differentiation of HL-60 cells Exp Cell Res 2000 256 264 71
28. Kanaysu-Toyoda T Yamaguchi T Oshizawa T Uchida E Hayakawa T The role of c-Myc on granulocyte colony-stimulating factor-dependent neutrophilic proliferation and differentiation of HL-60 cells Biochem Pharmacol 2003 66 133 40
29. Van Waardenburg RC Meijer C Burger H Nooter K De Vries EG Mulder NH et al. Effects of an inducible anti-sense c-myc gene transfer in a drug resistant human small-cell-lung-carcinoma cell line Int J Cancer 1997 73 544 50
30. Kimura S Maekawa T Hirakawa K Murakami A Abe T Alterations of c-myc expression by antisense oligodeoxynucleotides enhance the induction of apoptosis in HL-60 cells Cancer Res 1995 55 1379 84
31. Leonetti C D'Agnano I Lozupone F Valentini A Geiser T Zon G et al. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and in mice J Natl Cancer Inst 1996 88 419 29
32. Hoffman B Amanullah A Shafarenko M Liebermann DA The proto-oncogene c-myc in hematopoietic development and leukemogenesis Oncogene 2002 21 3414 21
33. Dimberg A Bahram F Karlberg I Larsson LG Nilsson K Oberg F Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27 (Kip1) Blood 2002 99 2199 206
34. Henriksson M Luscher B Proteins of the Myc network: essential regulators of cell growth and differentiation Adv Cancer Res 1996 68 109 82
35. Shafarenko M Amanullah A Gregory B Liebermann DA Hoffman B Fos modulates myeloid cell survival and differentiation and partially abrogates the c-Myc block in terminal myeloid differentiation Blood 2004 103 4259 67